Literature DB >> 31258808

IDENTICAL TWIN SISTERS WITH CLOSE ONSET OF GRAVES' DISEASE AND WITH MULTIPLE HLA SUSCEPTIBILITY ALLELES FOR GRAVES' DISEASE.

T Matsuo1, Y Ushiroda1.   

Abstract

CONTEXT: Autoimmune thyroid disease is considered a multifactorial disorder in which autoimmunity against thyroid antigens is facilitated by exposure to endogenous and environmental factors. We present here a rare case of identical female twins who developed consecutively Graves' disease within a few months and had three HLA susceptibility alleles for the development of Graves' disease.
SUBJECTS: A 28-year-old woman was referred to our hospital complaining of thirst, sweating, palpitations, tremor and skin rash. Laboratory data showed hyperthyroidism with antibodies against the thyroid stimulating hormone receptor and ultrasonography of the thyroid revealed enlargement with hypervascularity. Her identical twin was referred to our hospital because of similar symptoms. RESULT: We diagnosed them with Graves' disease and both were treated with methimazole. Human leukocyte antigen genotyping showed that both twins possessed the DRB1*04:05, DQB1*04:01:01, DPB1*05:01 haplotype, which confers susceptibility to Graves' disease.
CONCLUSIONS: This case supports the hypothesis that interaction of multiple human leukocyte antigen susceptibility alleles as well as genetic background and environmental factors might synergistically contribute the close timing in Graves' disease onset.

Entities:  

Keywords:  Idiopathic bilateral adrenal hemorrhage; spontaneous regression

Year:  2016        PMID: 31258808      PMCID: PMC6586756          DOI: 10.4183/aeb.2016.91

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  27 in total

1.  Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts.

Authors:  T H Brix; K O Kyvik; K Christensen; L Hegedüs
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

Review 2.  Genetic susceptibility in thyroid autoimmunity.

Authors:  Yoshiyuki Ban; Yaron Tomer
Journal:  Pediatr Endocrinol Rev       Date:  2005-09

3.  Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study.

Authors:  T H Brix; P S Hansen; K O Kyvik; L Hegedüs
Journal:  Arch Intern Med       Date:  2000-03-13

4.  HLA and CTLA4 polymorphisms may confer a synergistic risk in the susceptibility to Graves' disease.

Authors:  Megumi Takahashi; Akinori Kimura
Journal:  J Hum Genet       Date:  2010-03-19       Impact factor: 3.172

5.  Association of HLA-DR, -DQ genotype and CTLA-4 gene polymorphism with Graves' disease in Japanese children.

Authors:  Saika Iwama; Ayako Ikezaki; Noriko Kikuoka; Hye-Sook Kim; Hisafumi Matsuoka; Tatsuo Yanagawa; Hirokazu Sato; Mari Hoshi; Tateo Sakamaki; Shigetaka Sugihara
Journal:  Horm Res       Date:  2005-01-03

Review 6.  The genetic basis of thyroid autoimmunity.

Authors:  Eric M Jacobson; Yaron Tomer
Journal:  Thyroid       Date:  2007-10       Impact factor: 6.568

7.  [Clinical studies on 3 pairs of monozygotic twin sisters affected by Graves' disease].

Authors:  O Mimaru; M Yoshimoto; T Sakamaki; K Mayumi; T Sugimoto; S Kokei; H Oyanagi; T Inoue; S Suzuki; S Iino
Journal:  Nihon Naibunpi Gakkai Zasshi       Date:  1991-11-20

Review 8.  The environment and autoimmune thyroid diseases.

Authors:  Mark F Prummel; Thea Strieder; Wilmar M Wiersinga
Journal:  Eur J Endocrinol       Date:  2004-05       Impact factor: 6.664

Review 9.  The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.

Authors:  Eric M Jacobson; Yaron Tomer
Journal:  J Autoimmun       Date:  2007-03-21       Impact factor: 7.094

10.  HLA-A and DPB1 loci confer susceptibility to Graves' disease.

Authors:  R P Dong; A Kimura; R Okubo; H Shinagawa; H Tamai; Y Nishimura; T Sasazuki
Journal:  Hum Immunol       Date:  1992-11       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.